vs
Side-by-side financial comparison of ACNB CORP (ACNB) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $47.2M, roughly 1.2× ACNB CORP). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 42.2%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $-167.0M).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
ACNB vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $57.6M |
| Net Profit | $10.8M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | 27.9% | — |
| Net Margin | 22.9% | — |
| Revenue YoY | 42.2% | 94.1% |
| Net Profit YoY | 63.8% | 71.6% |
| EPS (diluted) | $1.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $57.6M | ||
| Q3 25 | $50.9M | $49.5M | ||
| Q2 25 | $50.3M | $39.5M | ||
| Q1 25 | $43.5M | $28.5M | ||
| Q4 24 | $33.2M | $29.7M | ||
| Q3 24 | $34.1M | $16.4M | ||
| Q2 24 | $33.3M | $7.3M | ||
| Q1 24 | $31.6M | — |
| Q4 25 | $10.8M | — | ||
| Q3 25 | $14.9M | $-30.0M | ||
| Q2 25 | $11.6M | $-75.8M | ||
| Q1 25 | $-272.0K | $-94.3M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $7.2M | $-85.6M | ||
| Q2 24 | $11.3M | $-91.4M | ||
| Q1 24 | $6.8M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | 27.9% | — | ||
| Q3 25 | 37.2% | -30.8% | ||
| Q2 25 | 29.7% | -151.7% | ||
| Q1 25 | -1.3% | -276.5% | ||
| Q4 24 | 24.8% | — | ||
| Q3 24 | 27.6% | -433.0% | ||
| Q2 24 | 42.8% | -1055.4% | ||
| Q1 24 | 26.9% | — |
| Q4 25 | 22.9% | — | ||
| Q3 25 | 29.2% | -60.5% | ||
| Q2 25 | 23.2% | -191.9% | ||
| Q1 25 | -0.6% | -330.7% | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 21.1% | -523.3% | ||
| Q2 24 | 33.9% | -1248.6% | ||
| Q1 24 | 21.4% | — |
| Q4 25 | $1.10 | — | ||
| Q3 25 | $1.42 | $-0.41 | ||
| Q2 25 | $1.11 | $-1.05 | ||
| Q1 25 | $-0.03 | $-1.31 | ||
| Q4 24 | $0.77 | — | ||
| Q3 24 | $0.84 | $-1.32 | ||
| Q2 24 | $1.32 | $-1.56 | ||
| Q1 24 | $0.80 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $130.0M |
| Total DebtLower is stronger | $255.4M | $209.1M |
| Stockholders' EquityBook value | $420.0M | $-438.2M |
| Total Assets | $3.2B | $259.1M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $130.0M | ||
| Q3 25 | $102.1M | $135.2M | ||
| Q2 25 | $103.1M | $149.6M | ||
| Q1 25 | $123.6M | $212.3M | ||
| Q4 24 | $47.3M | $297.3M | ||
| Q3 24 | $58.1M | $334.7M | ||
| Q2 24 | $86.3M | $276.2M | ||
| Q1 24 | $53.1M | — |
| Q4 25 | $255.4M | $209.1M | ||
| Q3 25 | $255.4M | $207.1M | ||
| Q2 25 | $255.4M | $205.1M | ||
| Q1 25 | $255.3M | $203.2M | ||
| Q4 24 | $255.3M | $201.4M | ||
| Q3 24 | $255.3M | $175.7M | ||
| Q2 24 | $255.3M | $174.4M | ||
| Q1 24 | $255.3M | — |
| Q4 25 | $420.0M | $-438.2M | ||
| Q3 25 | $408.6M | $-422.5M | ||
| Q2 25 | $395.2M | $-405.8M | ||
| Q1 25 | $386.9M | $-338.4M | ||
| Q4 24 | $303.3M | $-253.6M | ||
| Q3 24 | $306.8M | $-187.1M | ||
| Q2 24 | $289.3M | $-233.8M | ||
| Q1 24 | $279.9M | — |
| Q4 25 | $3.2B | $259.1M | ||
| Q3 25 | $3.3B | $240.3M | ||
| Q2 25 | $3.3B | $250.2M | ||
| Q1 25 | $3.3B | $294.2M | ||
| Q4 24 | $2.4B | $378.3M | ||
| Q3 24 | $2.4B | $387.0M | ||
| Q2 24 | $2.5B | $319.4M | ||
| Q1 24 | $2.4B | — |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.91× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $-166.8M |
| Free Cash FlowOCF − Capex | $52.6M | $-167.0M |
| FCF MarginFCF / Revenue | 111.4% | -290.0% |
| Capex IntensityCapex / Revenue | 2.3% | 0.4% |
| Cash ConversionOCF / Net Profit | 4.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $-166.8M | ||
| Q3 25 | $23.2M | $-14.1M | ||
| Q2 25 | $17.8M | $-62.7M | ||
| Q1 25 | $-71.0K | $-84.9M | ||
| Q4 24 | $39.8M | $-266.8M | ||
| Q3 24 | $13.6M | $-63.6M | ||
| Q2 24 | $9.7M | $-70.7M | ||
| Q1 24 | $10.8M | — |
| Q4 25 | $52.6M | $-167.0M | ||
| Q3 25 | $22.8M | $-14.1M | ||
| Q2 25 | $17.6M | $-62.8M | ||
| Q1 25 | $-730.0K | $-84.9M | ||
| Q4 24 | $38.8M | $-266.9M | ||
| Q3 24 | $13.3M | $-63.6M | ||
| Q2 24 | $9.4M | $-70.8M | ||
| Q1 24 | $10.7M | — |
| Q4 25 | 111.4% | -290.0% | ||
| Q3 25 | 44.7% | -28.6% | ||
| Q2 25 | 35.0% | -159.0% | ||
| Q1 25 | -1.7% | -297.9% | ||
| Q4 24 | 117.0% | -899.8% | ||
| Q3 24 | 39.1% | -389.0% | ||
| Q2 24 | 28.3% | -966.2% | ||
| Q1 24 | 33.9% | — |
| Q4 25 | 2.3% | 0.4% | ||
| Q3 25 | 0.8% | 0.1% | ||
| Q2 25 | 0.4% | 0.2% | ||
| Q1 25 | 1.5% | 0.1% | ||
| Q4 24 | 2.9% | 0.5% | ||
| Q3 24 | 0.7% | 0.3% | ||
| Q2 24 | 0.9% | 0.6% | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 4.96× | — | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 1.88× | — | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
